Developments in smoking cessation interventions for patients with chronic obstructive pulmonary disease in the past 5 years: a scoping review

References

• World Health Organization. The Global Health Observatory, Global Health Estimates: Life Expectancy and Leading Causes of Death and Disability. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates. Accessed Feb 2022.
   Google Scholar
• Montes de Oca M. Smoking cessation/vaccinations. Clin Chest Med. 2020;41(3):495–512.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO highlights huge scale of tobacco-related lung disease deaths. https://www.who.int/news/item/29-05-2019-who-highlights-huge-scale-of-tobacco-related-lung-disease-deaths. Accessed Jul 2022.
   Google Scholar
• Fletcher C, Peto R. Natural history of chronic respiratory tract obstruction. Bull Int Union Tuberc. 1978;53(2):79–87.
   PubMedGoogle Scholar
• Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest. 2004;126(5):1443–1451.
   PubMed Web of Science ®Google Scholar
• van der Meer RM, Wagena EJ, Ostelo RW, et al. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2003;2003(2):Cd002999.
   Google Scholar
• Zhang MW, Ho RC, Cheung MW, et al. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217–223.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The lung health study. Jama. 1994;272(19):1497–1505.
   PubMed Web of Science ®Google Scholar
• Lou P, Zhu Y, Chen P, et al. Supporting smoking cessation in chronic obstructive pulmonary disease with behavioral intervention: a randomized controlled trial. BMC Fam Pract. 2013;14(1):91.
   PubMedGoogle Scholar
• Lei S, Li M, and Duan W, et al. The long-term outcomes of tobacco control strategies based on the cognitive intervention for smoking cessation in COPD patients. Respir Med. 2020;172: 106155.
   PubMed Web of Science ®Google Scholar
• van Eerd EAM, van der Meer RM, van Schayck OCP, et al. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;2019(8). DOI:10.1002/14651858.CD010744.pub2
   Google Scholar
• Global initiative for chronic obstructive lung disease. global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2022 report). 2021. https://goldcopd.org/2022-gold-reports-2/. Accessed Feb 2022.
   Google Scholar
• Chen D, Wu LT. Smoking cessation interventions for adults aged 50 or older: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:14–24.
   PubMed Web of Science ®Google Scholar
• Jiménez-Ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015;46(1):61–79.
   PubMed Web of Science ®Google Scholar
• Hashimoto R, Tomioka H, Wada T, et al. Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependence. Respir Investig. 2020;58(5):387–394.
   PubMed Web of Science ®Google Scholar
• Ellerbeck EF, Nollen N, Hutcheson TD, et al., Effect of long-term nicotine replacement therapy vs standard smoking cessation for smokers with chronic lung disease: a randomized clinical trial. JAMA network open. 2018;1(5):e181843.
   PubMed Web of Science ®Google Scholar
• Yang DX, Gu CJ, Ni L, et al. Assessment of efficacy of medication combined with WeChat platform for quitting smoking in patients with chronic obstructive pulmonary disease. J Shanghai Jiaotong Univ (Medical Science). 2016;36(3):385‐389.
   Google Scholar
• Xin C, Xia Z, Jiang C, et al. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence. 2016;10:1197‐1203.
   PubMed Web of Science ®Google Scholar
• Zhang A, Wang L, Long L, et al. Effectiveness and economic evaluation of hospital-outreach pulmonary rehabilitation for patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:1071‐1083.
   Web of Science ®Google Scholar
• Suhaj A, Manu MK, Unnikrishnan MK, et al. Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients - a randomized controlled study. J Clin Pharm Ther. 2016;41(1):78–83.
   PubMed Web of Science ®Google Scholar
• Wang L, Guo Y, Wang M, et al., A mobile health application to support self-management in patients with chronic obstructive pulmonary disease: a randomised controlled trial. Clin Rehabil. 2021;35(1):90–101.
   PubMed Web of Science ®Google Scholar
• Franks AS, Sando K, McBane S. Do electronic cigarettes have a role in tobacco cessation? Pharmacotherapy. 2018;38(5):555–568.
   PubMed Web of Science ®Google Scholar
• Polosa R, Morjaria JB, and Prosperini U, et al. COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up. Ther Adv Chronic Dis. 2020;11: 2040622320961617.
   Web of Science ®Google Scholar
• Morjaria JB, Mondati E, Polosa R. E-cigarettes in patients with COPD: current perspectives. Int J Chron Obstruct Pulmon Dis. 2017;12:3203–3210.
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
   PubMed Web of Science ®Google Scholar
• Zeng F, Chen C-I, Mastey V, et al. Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims. Clin Ther. 2011;33(2):225–234.
   PubMed Web of Science ®Google Scholar
• Schauer GL, Wheaton AG, Malarcher AM, et al. Health-care provider screening and advice for smoking cessation among smokers with and without COPD: 2009-2010 national adult tobacco survey. Chest. 2016;149(3):676–684.
   PubMed Web of Science ®Google Scholar
• Melzer AC, Feemster LC, Collins MP, et al. Predictors of pharmacotherapy for tobacco use among veterans admitted for COPD: the role of disparities and tobacco control processes. J Gen Intern Med. 2016;31(6):623–629.
   PubMed Web of Science ®Google Scholar
• Guanzhang J, Maclagan LC, To T, et al. Smoking and smoking cessation among people with chronic obstructive pulmonary disease (COPD). Can J Respir Crit Care Sleep Med. 2019;5(4):256–260.
   Web of Science ®Google Scholar
• Cedillo S, Sicras-Mainar A, Jiménez-Ruiz CA, et al. Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective. Eur Addict Res. 2017;23(1):7–18.
   PubMed Web of Science ®Google Scholar
• Kotz D, Batra A, Kastaun S. Smoking cessation attempts and common strategies employed. Dtsch Arztebl Int. 2020;117(1–2):7–13.
   PubMed Web of Science ®Google Scholar
• Wang X, Babb S, Xu X, et al. Receipt of cessation treatments among medicaid enrollees trying to quit smoking. Nicotine Tob Res. 2021;23(6):1074–1078.
   PubMed Web of Science ®Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473.
   PubMed Web of Science ®Google Scholar
• Munn Z, Peters MDJ, Stern C, et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143.
   PubMed Web of Science ®Google Scholar
• Oml AH, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–23.
   Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
   PubMed Web of Science ®Google Scholar
• Van Eck NJ, Waltman L. VOSviewer manual—version 1.6.10. Available online: https://www.vosviewer.com/documentation/Manual_VOSviewer_1.6.10.pdf ( accessed on 14 March 2022).
   Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Jiménez-Ruiz CA, García M, Martínez MA, et al. Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study. Monaldi Arch Chest Dis. 2017;87(3):119–122.
   Web of Science ®Google Scholar
• Fai SC, Yen GK, Malik N. Quit rates at 6 months in a pharmacist-led smoking cessation service in Malaysia. Can Pharm J (Ott). 2016;149(5):303–312.
   PubMedGoogle Scholar
• Melzer AC, Feemster LC, Collins MP, et al. Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD. J Hosp Med. 2016;11(4):257–263.
   PubMed Web of Science ®Google Scholar
• Qin R, Liu Z, Zhou X, et al. Adherence and efficacy of smoking cessation treatment among patients with COPD in China. Int J Chron Obstruct Pulmon Dis. 2021;16:1203‐1214.
   Web of Science ®Google Scholar
• Le Mao R, Tromeur C, Paleiron N, et al., Effect of early initiation of varenicline on smoking cessation in COPD patients admitted for exacerbation: the save randomized clinical trial. COPD. 2020;17(1):7–14.
   PubMedGoogle Scholar
• Zarghami M, Taghizadeh F, Sharifpour A, et al. Efficacy of guided self-change for smoking cessation in chronic obstructive pulmonary disease patients: a randomized controlled clinical trial. Tob Induc Dis. 2019;17(December):90.
   PubMedGoogle Scholar
• Zarghami M, Taghizadeh F, Sharifpour A, et al. Efficacy of smoking cessation on stress, anxiety, and depression in smokers with chronic obstructive pulmonary disease: a randomized controlled clinical trial. Addict Health. 2018;10(3):137‐147.
   Google Scholar
• Sharifpour A, Taghizadeh F, Zarghami M, et al. The effectiveness of individual interventions on smoking cessation of chronic obstructive pulmonary disease patients. J Nurs & Midwifery Sci. 2020;7(1):13‐21.
   Google Scholar
• Sansores RH, Ramírez-Venegas A, Arellano-Rocha R, et al. Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study. Ther Adv Respir Dis. 2016;10(5):383–390.
   PubMed Web of Science ®Google Scholar
• Hernández Zenteno RJ, Lara DF, Venegas AR, et al. Varenicline for long term smoking cessation in patients with COPD. Pulm Pharmacol Ther. 2018;53:116–120.
   PubMed Web of Science ®Google Scholar
• Trofor AC, Papadakis S, Lotrean L, et al. Tobacco treatment guideline for high risk groups: a pilot study in patients with chronic obstructive pulmonary disease. Tob Induc Dis. 2018;16(April). DOI:10.18332/tid/85944
   Google Scholar
• Melzer AC, Clothier BA, Japuntich SJ, et al. Comparative effectiveness of proactive tobacco treatment among smokers with and without chronic lower respiratory disease. Ann Am Thorac Soc. 2018;15(3):341–347.
   PubMed Web of Science ®Google Scholar
• Gobarani RK, Zwar NA, Russell G, et al. Smoking cessation intervention in Australian general practice: a secondary analysis of a cluster randomised controlled trial. Br J Gen Pract. 2021;71(707):e458‐e464.
   PubMed Web of Science ®Google Scholar
• Streck JM, Ochalek TA, Miller ME, et al. Promoting smoking abstinence among patients with chronic obstructive pulmonary disease: initial feasibility. Prev Med Rep. 2018;11:176‐179.
   PubMedGoogle Scholar
• Stallings-Smith S, Hamadi HY, Peterson BN, et al. Smoke-free policies and 30-day readmission rates for chronic obstructive pulmonary disease. Am J Prev Med. 2019;57(5):621–628.
   PubMed Web of Science ®Google Scholar
• Hamadi H, Stallings-Smith S, Apatu E, et al. Smoke-free policies and 30-day mortality rates for chronic obstructive pulmonary disease. Int J Health Policy Manag. 2021. DOI:10.34172/ijhpm.2021.74
   PubMed Web of Science ®Google Scholar
• Bui QTH, Nguyen ATD. Effectiveness of education intervention carried out by clinical pharmacist on quality of life of patients with COPD: a randomized controlled trial. Pharm Sci Asia. 2020;47(3):238–245.
   Google Scholar
• Kuint R, Cohen Goichman P, Mizrachi A, et al. The effect of a multidisciplinary integrated approach on outcomes in chronic obstructive pulmonary disease. Isr Med Assoc J. 2020;22(12):761–764.
   PubMed Web of Science ®Google Scholar
• Peckens S, Adelman MM, Ashcraft AM, et al. Improving Chronic Obstructive Pulmonary Disease (COPD) symptoms using a team-based approach. J Am Board Fam Med. 2020;33(6):978–985.
   PubMed Web of Science ®Google Scholar
• Liang J, Abramson MJ, Russell G, et al. Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial. Eur Respir J. 2019;53(4). DOI:10.1183/13993003.01530-2018
   Web of Science ®Google Scholar
• Tanaka K, Senjyu H, Tawara Y, et al. Effects of systematic intervention for chronic obstructive pulmonary disease on follow-up and smoking cessation rates and changes of the pulmonary function: a 7-year longitudinal study in a Japanese rural city. Intern Med. 2018;57(16):2315–2323.
   PubMed Web of Science ®Google Scholar
• van Boven JF, Stuurman-Bieze AG, Hiddink EG, et al. Effects of targeting disease and medication management interventions towards patients with COPD. Curr Med Res Opin. 2016;32(2):229–239.
   PubMed Web of Science ®Google Scholar
• Polosa R, Morjaria JB, Caponnetto P, et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res. 2016;17(1):166.
   PubMedGoogle Scholar
• Polosa R, Morjaria JB, Prosperini U, et al. Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up. Int J Chron Obstruct Pulmon Dis. 2018;13:2533–2542.
   PubMedGoogle Scholar
• Polosa R, Morjaria JB, Prosperini U, et al., Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up. Intern Emerg Med. 2021;16(3):687–696.
   PubMed Web of Science ®Google Scholar
• Tøttenborg SS, Clark AJ, Thomsen RW, et al. Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study. Int J Chron Obstruct Pulmon Dis. 2018;13:1775–1781.
   PubMed Web of Science ®Google Scholar
• Van Eerd EAM, Risør MB, Spigt M, et al. Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. NPJ Prim Care Respir Med. 2017;27(1). DOI:10.1038/s41533-017-0038-6
   PubMedGoogle Scholar
• Liang J, Abramson MJ, Zwar NA, et al. Diagnosing COPD and supporting smoking cessation in general practice: evidence practice gaps. Med J Aust. 2018;208(1):29–34.
   PubMed Web of Science ®Google Scholar
• Aumann I, Tedja L, Graf Von Der Schulenburg JM. Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement -A qualitative analysis. Tob Induc Dis. 2016;14(1). DOI:10.1186/s12971-016-0097-4
   PubMedGoogle Scholar
• Chen XRC, Fu SN, Leung WK, et al. Clinical audit on Chronic Obstructive Pulmonary Disease (COPD) management in primary care: a quality improvement project from Hong Kong. Int J Chron Obstruct Pulmon Dis. 2021;16:1901–1911.
   PubMed Web of Science ®Google Scholar
• Chen XRC, Leung SH, Li YC. Chronic Obstructive Pulmonary Disease (COPD) management in the community: how could primary care team contribute? BMC Fam Pract. 2020;21(1):184.
   PubMed Web of Science ®Google Scholar
• Khan A, Dickens AP, Adab P, et al. Self-management behaviour and support among primary care COPD patients: cross-sectional analysis of data from the Birmingham chronic obstructive pulmonary disease cohort. NPJ Prim Care Respir Med. 2017;27(1):46.
   PubMedGoogle Scholar
• Stegberg M, Hasselgren M, Montgomery S, et al. Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD. Eur Clin Respir J. 2018;5(1). DOI:10.1080/20018525.2017.1421389
   PubMedGoogle Scholar
• O’Halloran L, Purcell A, Ryan E, et al. A snapshot of chronic obstructive pulmonary disease management in general practice in Ireland. Ir J Med Sci. 2021;190(3):1055–1061.
   PubMed Web of Science ®Google Scholar
• Wirth IM, Penz ED, Marciniuk DD. Examination of COPD management in patients hospitalized with an acute exacerbation of COPD. Can J Respir Crit Care Sleep Med. 2020;6(1):14–23.
   Web of Science ®Google Scholar
• Lutter JI, Lukas M, Schwarzkopf L, et al. Utilization and determinants of use of non-pharmacological interventions in COPD: results of the COSYCONET cohort. Respir Med. 2020;171:106087.
   PubMed Web of Science ®Google Scholar
• Baliunas D, Zawertailo L, Voci S, et al. Variability in patient sociodemographics, clinical characteristics, and healthcare service utilization among 107,302 treatment seeking smokers in Ontario: a cross-sectional comparison. PloS one. 2020;15(7):e0235709.
   PubMed Web of Science ®Google Scholar
• Kotz D, Viechtbauer W, Simpson CR, et al., Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease. Thorax. 2017;72(10):905–911.
   PubMed Web of Science ®Google Scholar
• Kongsakon R, Sruamsiri R. A cost-utility study of smoking cessation interventions for patients with chronic obstructive pulmonary disease in Thailand. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand]. 2019;102(4):463‐471.
   Google Scholar
• The United States Public Health Service Office of the Surgeon General. National center for chronic disease prevention and health promotion (US) office on smoking and health. smoking cessation: a report of the surgeon general. Washington (DC): US Department of Health and Human Services. 2020.
   Google Scholar
• Leone FT, Zhang Y, Evers-Casey S, et al. Initiating pharmacologic treatment in tobacco-dependent adults. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;202(2):e5–e31.
   PubMed Web of Science ®Google Scholar
• Thomas KH, Dalili MN, López-López JA, et al. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess. 2021;25(59):1–224.
   Web of Science ®Google Scholar
• Mills EJ, Thorlund K, Eapen S, et al. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014;129(1):28–41.
   PubMed Web of Science ®Google Scholar
• Anthenelli RM, Benowitz NL, West R, et al., Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–2520.
   PubMed Web of Science ®Google Scholar
• Howes S, Hartmann-Boyce J, Livingstone-Banks J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2020;4(4):Cd000031.
   PubMedGoogle Scholar
• Panagioti M, Scott C, Blakemore A, et al. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:1289–1306.
   PubMed Web of Science ®Google Scholar
• Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;31(5):CD000165.
   Google Scholar
• Clinical Practice Guideline Treating Tobacco Use and Dependence. Update panel, liaisons, and staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. public health service report. Am J Prev Med. 2008;35(2):158–176.
   PubMed Web of Science ®Google Scholar
• Schroeder SA. What to do with a patient who smokes. Jama. 2005;294(4):482–487.
   PubMed Web of Science ®Google Scholar
• Vidrine JI, Shete S, Cao Y, et al. Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med. 2013;173(6):458–464.
   PubMed Web of Science ®Google Scholar
• The U.S. Preventive Services Task Force. Final update summary: tobacco smoking cessation in adults, including pregnant women: Behavioral and Pharmacotherapy Interventions. 2015. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/tobacco-use-in-adults-and-pregnant-women-counselingand-interventions1. Accessed Feb 2022.
   Google Scholar
• Kao CK, Liebovitz DM. Consumer mobile health apps: current state, barriers, and future directions. PM R. 2017;9(5S):S106–S115.
   PubMedGoogle Scholar
• Taber JM, Klein WM, Ferrer RA, et al. A pilot test of self-affirmations to promote smoking cessation in a national smoking cessation text messaging program. JMIR Mhealth Uhealth. 2016;4(2):e71.
   PubMed Web of Science ®Google Scholar
• Augustson E, Cole-Lewis H, Sanders A, et al. Analysing user-reported data for enhancement of smokefreetxt: a national text message smoking cessation intervention. Tob Control. 2017;26(6):683–689.
   PubMed Web of Science ®Google Scholar
• Whittaker R, McRobbie H, Bullen C, et al. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10(10):Cd006611.
   PubMedGoogle Scholar
• Taylor GMJ, Dalili MN, Semwal M, et al. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2017;9(9):Cd007078.
   PubMedGoogle Scholar
• Tzelepis F, Paul CL, and Williams CM, et al. Real-time video counselling for smoking cessation. Cochrane Database Syst Rev. 2019;2019(10):CD012659.
   Google Scholar
• Soriano JB, Kendrick PJ, Paulson KR, GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596.
   PubMed Web of Science ®Google Scholar
• Kampmeijer R, Pavlova M, Tambor M, et al. The use of e-health and m-health tools in health promotion and primary prevention among older adults: a systematic literature review. BMC Health Serv Res. 2016;16(Suppl S5):290.
   PubMedGoogle Scholar
• Sheffer MA, Baker TB, Fraser DL, et al. Fax referrals, academic detailing, and tobacco quitline use: a randomized trial. Am J Prev Med. 2012;42(1):21–28.
   PubMed Web of Science ®Google Scholar
• Markham CM, Craig Rushing S, Jessen C, et al. Internet-based delivery of evidence-based health promotion programs among American Indian and Alaska native youth: a case study. JMIR Res Protoc. 2016;5(4):e225.
   PubMed Web of Science ®Google Scholar
• Anguiano B, Brown-Johnson C, Rosas LG, et al. Latino adults’ perspectives on treating tobacco use via social media. JMIR Mhealth Uhealth. 2017;5(2):e12.
   PubMed Web of Science ®Google Scholar